New drug aims to stop the dizziness of standing up
Symptom relief
Recruiting now
This study tests a new drug called CST-3056 in 12 adults with neurogenic orthostatic hypotension (a sharp drop in blood pressure when standing) caused by Parkinson's disease or pure autonomic failure. The goal is to see if the drug can improve blood pressure and reduce symptoms l…
Phase: PHASE2 • Sponsor: CuraSen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC